Credit Agricole’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12M Buy
55,000
+40,000
+267% +$8.87M 0.03% 358
2025
Q4
$3.43M Buy
+15,000
New +$3.42M 0.01% 705
2025
Q1
Sell
-50,000
Closed -$8.88M 1267
2024
Q4
$8.88M Hold
50,000
0.03% 417
2024
Q3
$9.87M Hold
50,000
0.04% 286
2024
Q2
$8.58M Hold
50,000
0.05% 267
2024
Q1
$8.23M Sell
50,000
-35,000
-41% -$6.03M 0.09% 189
2023
Q4
$13.2M Buy
85,000
+50,000
+143% +$7.29M 0.15% 117
2023
Q3
$5.22M Hold
35,000
0.08% 182
2023
Q2
$4.72M Hold
35,000
0.09% 177
2023
Q1
$5.58M Sell
35,000
-10,000
-22% -$1.53M 0.11% 145
2022
Q4
$7.27M Hold
45,000
0.15% 120
2022
Q3
$6.04M Buy
45,000
+10,000
+29% +$1.43M 0.11% 122
2022
Q2
$5.36M Hold
35,000
0.13% 135
2022
Q1
$5.67M Hold
35,000
0.1% 146
2021
Q4
$4.74M Hold
35,000
0.08% 173
2021
Q3
$3.77M Buy
+35,000
New +$4M 0.07% 171

Other funds holding ABBV

Credit Agricole's ABBV Position: Q1 2026 in Review

Credit Agricole reduced its AbbVie (ABBV) stake by 2.5% in Q1 2026, selling an estimated $5.08M and leaving 897,538 shares worth $195M. The position accounts for 0.51% of the portfolio, ranked #28.

Credit Agricole first reported a position in ABBV in Q3 2013 and has held it in 46 quarters since. The position peaked at $210M in Q4 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Credit Agricole held 897,538 shares of AbbVie worth $195M as of Q1 2026.
  • Credit Agricole sold 22,890 AbbVie shares in Q1 2026, an estimated $5.08M.
  • AbbVie made up 0.51% of Credit Agricole's portfolio in Q1 2026, its #28 holding.
  • Credit Agricole first reported a position in AbbVie in Q3 2013 and has held it in 46 quarters since.
  • Credit Agricole's AbbVie position peaked at $210M in Q4 2025.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Credit Agricole's 13F filing for Q1 2026, filed 15 May 2026.